175 related articles for article (PubMed ID: 22838110)
1. [The risk behavior of drug addicts requires holistic approach from the society. Syringe exchange and methadone-/buprenorphine treatment are important elements].
Håkansson AC
Lakartidningen; 2012 Jun 19-26; 109(25):1216-7. PubMed ID: 22838110
[No Abstract] [Full Text] [Related]
2. [Widespread risk behavior among injecting drug users. Over 80 percent HCV-infected--7 percent have HIV, as demonstrated by the first baseline study].
Hillgren K; Sarkar K; Elofsson S; Britton S
Lakartidningen; 2012 Jun 19-26; 109(25):1221-5. PubMed ID: 22838111
[No Abstract] [Full Text] [Related]
3. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants.
Disney E; Kidorf M; Kolodner K; King V; Peirce J; Beilenson P; Brooner RK
J Nerv Ment Dis; 2006 Aug; 194(8):577-83. PubMed ID: 16909065
[TBL] [Abstract][Full Text] [Related]
4. Mitigating the risk of HIV infection with opioid substitution treatment.
Gowing LR; Hickman M; Degenhardt L
Bull World Health Organ; 2013 Feb; 91(2):148-9. PubMed ID: 23554530
[No Abstract] [Full Text] [Related]
5. Psychosocial risk factors for HIV transmission in male drug abusers.
Brook JS; Brook DW; Whiteman M; Roberto J; Masci JR; De Catalogne J; Amundsen F
Genet Soc Gen Psychol Monogr; 1993 Aug; 119(3):369-87. PubMed ID: 8243990
[TBL] [Abstract][Full Text] [Related]
6. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
[TBL] [Abstract][Full Text] [Related]
7. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
[TBL] [Abstract][Full Text] [Related]
8. Needle exchange programs and drug infection behavior.
DeSimone J
J Policy Anal Manage; 2005; 24(3):559-77. PubMed ID: 15973795
[TBL] [Abstract][Full Text] [Related]
9. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA;
Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028
[TBL] [Abstract][Full Text] [Related]
10. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
Rittmannsberger H; Ruschak M; Silberbauer C
Nervenarzt; 1994 May; 65(5):338-44. PubMed ID: 8052337
[TBL] [Abstract][Full Text] [Related]
11. HIV risk behavior: antisocial personality disorder, drug use patterns, and sexual behavior among methadone maintenance admissions.
Nolimal D; Crowley TJ
NIDA Res Monogr; 1989; 95():401-2. PubMed ID: 2641008
[No Abstract] [Full Text] [Related]
12. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
Farnia M; Ebrahimi B; Shams A; Zamani S
Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
[TBL] [Abstract][Full Text] [Related]
13. Opiate addiction in China: current situation and treatments.
Tang YL; Zhao D; Zhao C; Cubells JF
Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
[TBL] [Abstract][Full Text] [Related]
14. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
15. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.
Vijay A; Bazazi AR; Yee I; Kamarulzaman A; Altice FL
J Subst Abuse Treat; 2015 Jul; 54():29-36. PubMed ID: 25841703
[TBL] [Abstract][Full Text] [Related]
16. [Do we need a methadone maintenance program?].
Täschner KL
Nervenarzt; 1991 Sep; 62(9):524-8. PubMed ID: 1956471
[No Abstract] [Full Text] [Related]
17. Opioid treatment in Ukraine risks losing momentum.
Bull World Health Organ; 2013 Feb; 91(2):87-8. PubMed ID: 23554519
[TBL] [Abstract][Full Text] [Related]
18. HIV seroconversion and risk factors among drug users receiving methadone maintenance treatment in China: A qualitative study.
Wang C; Shi CX; Zhang B; Chen H; Wang H; Zhang N; Rou K; Cao X; Luo W; Wu Z
Drug Alcohol Depend; 2016 Oct; 167():169-74. PubMed ID: 27567967
[TBL] [Abstract][Full Text] [Related]
19. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
[TBL] [Abstract][Full Text] [Related]
20. Were the changes to Sweden's maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity?
Romelsjö A; Engdahl B; Stenbacka M; Fugelstad A; Davstad I; Leifman A; Thiblin I
Addiction; 2010 Sep; 105(9):1625-32. PubMed ID: 20626377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
